研究园简易版
·
经典书籍
·
期刊文章
·
有原文
·
完整版(可多选筛选、搜索)
·
首页
搜索
2026 年 · Survival Analysis(生存分析)
202 篇,新的在前。点标题看作者和摘要。
回到 2026 年
Reproducible Life‐Expectancy Eligibility Criteria for Oncology Studies: Uncertainty Quantification for Machine Learning‐Derived Survival Screening Rules
· SiM · 2026-11-14 · 在第 1 页
Bayesian Hierarchical Piecewise‐Exponential Cause‐Specific Hazards for Posterior Predictive Validation of Competing‐Risks Models
· SiM · 2026-11-09 · 在第 1 页
Nonparametric sensitivity analysis for unobserved confounding with survival outcomes
· Biometrics · 2026-11-06 · 在第 1 页
Self-selection bias in evaluating the effectiveness of mammography screening: A sensitivity analysis on data from the German screening program
· SMMR · 2026-11-05 · 在第 1 页
Robustness intervals for competing risks analysis with causes of failure missing not at random
· Biometrics · 2026-11-04 · 在第 1 页
Robust transfer learning for accelerated failure time model
· SMMR · 2026-11-04 · 在第 1 页
Bivariate Copula Models With Event-Free Cure Effect for Survival Extrapolations and Individual-Level Correlation Analysis
· SiM · 2026-10-29 · 在第 2 页
Online Updating Mixture Cure Models for Large-Scale Survival Data Streams
· SiM · 2026-10-28 · 在第 2 页
Enhancing visual interpretability and explainability in functional survival trees and forests
· SMMR · 2026-10-26 · 在第 2 页
Marginal Analysis of Clustered Interval-Censored Competing Risks Data With Informative Cluster Size
· SiM · 2026-10-22 · 在第 2 页
Joint modeling of longitudinal measurements and survival outcomes in heart valve transplantation data
· SMMR · 2026-10-21 · 在第 2 页
Federated Time-to-Event Data Analysis Using Piecewise Exponential Regression in DataSHIELD
· SiM · 2026-10-18 · 在第 3 页
Dynamic Prediction in Mixture Cure Models: A Model-Based Landmarking Approach
· SiM · 2026-10-18 · 在第 3 页
Locally Estimated Scatterplot Smoothing for Censored Survival Data
· SiM · 2026-10-17 · 在第 3 页
Clinically Interpretable Time-To-Event Testing in Randomized Clinical Trials: Milestone Survival Combined With Restricted Mean Survival Time
· SiM · 2026-10-16 · 在第 3 页
A Max 0-1 Weighted Log-Rank Test for Time-to-Event Data With Random Delayed Treatment Effect
· SiM · 2026-10-16 · 在第 3 页
Treatment comparisons using a measurement during follow-up and a right-censored time-to-event outcome
· SMMR · 2026-10-15 · 在第 3 页
ROC-based methods for comparing two survival curves under non-proportional hazards with right, left, and doubly censored data
· SMMR · 2026-10-15 · 在第 3 页
Optimal Subsampling for the Proportional Mean Residual Life Model With Massive Survival Data
· SiM · 2026-10-12 · 在第 3 页
Taking Into Account the Susceptible Window for Exposures in Cox Proportional Hazards Model: A Way Using Splines to Model the Lag-Risk Relationship
· SiM · 2026-10-09 · 在第 4 页
Mixture cure rate model with artificial neural network for interval-censored data
· SMMR · 2026-10-09 · 在第 4 页
Joint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time
· SiM · 2026-10-09 · 在第 4 页
Group Sequential Sample Size for Comparing Two Survival Probabilities at a Specific Time Point
· SiM · 2026-10-09 · 在第 4 页
A Gaussian process model for chemoinformatics with application to the hazard classification of organic solvents
· Biometrics · 2026-10-09 · 在第 4 页
A Bayesian prevalence incidence cure model for estimating survival using electronic health records with incomplete baseline diagnoses
· SMMR · 2026-10-09 · 在第 4 页
Meta-analytical federated surveillance for incubation period with interval- and right-censored data with stochastic variational inference
· Biometrics · 2026-10-08 · 在第 4 页
Generative estimation of conditional survival function
· Biometrics · 2026-10-07 · 在第 4 页
Group-Specific Nonlinear Mixed Effects Models for Longitudinal Data With Realignment of Time
· SiM · 2026-10-01 · 在第 5 页
A regularized semiparametric cure-rate model with high-dimensional imaging data
· SMMR · 2026-09-30 · 在第 5 页
Flexible copula-based variable selection for interval-censored semi-competing risks data: application to aging research
· Biometrics · 2026-09-26 · 在第 5 页
Beyond Fixed Restriction Time: Adaptive Restricted Mean Survival Time Methods in Clinical Trials
· Biometrika · 2026-09-22 · 在第 6 页
A Novel Bayesian Distribution‐Free Survival Analysis
· SiM · 2026-09-22 · 在第 6 页
Doubly robust estimation of causal survival effects via inverse probability of treatment and censoring weighting and semi-parametric AFT models with variable selection
· SMMR · 2026-09-19 · 在第 6 页
Inferring leakage in imports of frozen seafood allowing for censoring, testing accuracy and a minimum positive prevalence
· Biometrics · 2026-09-18 · 在第 6 页
Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study
· SiM · 2026-09-17 · 在第 6 页
Estimating effects on cumulative incidence probabilities by direct polytomous regression and polytomous log-odds product
· Biometrics · 2026-09-16 · 在第 6 页
Event‐Driven Type Design for Clinical Trials With Recurrent Events
· SiM · 2026-09-14 · 在第 6 页
Built-in selection bias in proportional hazards models with omitted covariates: Simulation evidence and alternative approaches
· SMMR · 2026-09-12 · 在第 6 页
Joint Models of Two Longitudinal Biomarkers and Clustered Survival Data for Cluster‐Informed Dynamic Prediction With Application to Periodontitis
· SiM · 2026-09-08 · 在第 7 页
A Bayesian phase I/II trial design to optimizing dose–schedule regimen with competing risk outcomes
· SMMR · 2026-09-08 · 在第 8 页
A Group Structure Guided Ultra‐High Dimensional Feature Screening for Survival Outcome
· SiM · 2026-09-06 · 在第 8 页
Multilevel Network Meta-Regression With a Survival Outcome and an Application to Non-Small Cell Lung Cancer
· SiM · 2026-09-02 · 在第 8 页
Quantile regression for censored data with a cure fraction
· JASA · 2026-08-27 · 在第 8 页
The Cox–Aalen Rate Model for Recurrent Events With an Informative Terminal Event
· SiM · 2026-08-26 · 在第 9 页
A Bayesian Log‐Cauchy Mixture Cure Fraction Model for Heavy‐Tailed Survival Data: Implementation via OpenBUGS
· SiM · 2026-08-25 · 在第 9 页
Shape‐Based Partially Linear Single‐Index Cox Model for Alzheimer's Disease Conversion
· SiM · 2026-08-24 · 在第 9 页
Mini-batch Estimation for Deep Cox Models: Statistical Foundations and Practical Guidance
· JASA · 2026-08-19 · 在第 9 页
Sample Size and Power Calculations for Causal Inference in Observational Studies
· AoS · 2026-08-01 · 在第 11 页
P3LS: Point Process Partial Least Squares
· Biometrics · 2026-07-30 · 在第 11 页
A flexible bivariate cure model with shared random effect and associated inference and application to diabetic retinopathy data
· SMMR · 2026-07-30 · 在第 11 页
A Comparison of Testing Procedures for Detecting Short‐ and Long‐Term Effects of Biomarkers for Cancer Screening
· SiM · 2026-07-30 · 在第 11 页
Multilevel network meta-regression for general likelihoods: synthesis of individual and aggregate data with applications to survival analysis
· JRSSA · 2026-07-24 · 在第 13 页
Modelling emergency disaster mortality around the world: a network-based distributional inference approach
· JRSSA · 2026-07-24 · 在第 13 页
Counterfactual Q-learning via the linear Buckley–James method for longitudinal survival data
· JRSSA · 2026-07-24 · 在第 13 页
Bayesian hidden Markov model with time-to-event emissions for risk-prediction in cancer screening
· JRSSC · 2026-07-24 · 在第 14 页
A time-varying bivariate copula joint model for longitudinal and time-to-event data
· JRSSA · 2026-07-24 · 在第 14 页
A flexible rank-based framework for individualized treatment selection with mixed-type multivariate outcomes
· SMMR · 2026-07-17 · 在第 14 页
Adaptive spline-based weighting functions for blended survival curve extrapolation
· SMMR · 2026-07-16 · 在第 14 页
Estimating transmission parameters from stochastic epidemic models using survival analysis techniques
· SMMR · 2026-07-15 · 在第 14 页
On the Statistical Limitations of Landmark Analysis for Addressing Immortal Time Bias
· SiM · 2026-07-13 · 在第 15 页
Post-Reduction Inference for Confidence Sets of Models
· Biometrika · 2026-07-07 · 在第 15 页
Interim analysis in sequential multiple assignment randomized trials for survival outcomes
· Biometrics · 2026-07-07 · 在第 15 页
Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome
· SMMR · 2026-07-03 · 在第 16 页
A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme
· SMMR · 2026-07-03 · 在第 16 页
Principled Estimation and Prediction with Competing Risks: a Bayesian Nonparametric Approach
· JASA · 2026-07-02 · 在第 16 页
Semiparametric fiducial inference for Cox models
· JRSSB · 2026-07-01 · 在第 16 页
Regression analysis of misclassified current status data with potentially unknown test accuracy
· SMMR · 2026-07-01 · 在第 16 页
Moving From Individualized Risk‐Based Prevention to Benefit‐Based Prevention: Estimating Individualized Life‐Years Gained From Prevention Services as a Basis for Eligibility
· SiM · 2026-07-01 · 在第 16 页
Identifiable Copula‐Double‐Cox Models: A Fully Parametric Framework for Dependent Right‐Censored Survival Data
· SiM · 2026-07-01 · 在第 16 页
Mixture Modeling for Temporal Point Processes with Memory
· JASA · 2026-06-29 · 在第 16 页
Log-Gaussian Cox Process on General Metric Graphs
· Biometrika · 2026-06-29 · 在第 16 页
Optimizing Treatment Decision Estimation for Right‐Censored Survival Data Through Parameter Transfer Learning
· SiM · 2026-06-25 · 在第 17 页
Subgroup Analysis of Interval‐censored Failure Time Data With Application to Alzheimer's Disease
· SiM · 2026-06-24 · 在第 17 页
Joint analysis of longitudinal and recurrent event data: A functional regression approach with autoregressive frailty
· SMMR · 2026-06-23 · 在第 17 页
Maximum likelihood estimation in proportional odds regression model based on interval-censored event-time data
· SMMR · 2026-06-18 · 在第 18 页
Pseudo-observation regression for sequentially truncated data
· Biometrics · 2026-06-17 · 在第 18 页
Practical considerations when using the covariate-adjusted log-rank test for the analysis of time-to-event endpoints in oncology trials
· Biometrics · 2026-06-17 · 在第 18 页
Competing-triggering effect models for multitype recurrent event data
· Biometrics · 2026-06-17 · 在第 18 页
A bounded hazard ratio Cox model for the effect of time to treatment on mortality
· SMMR · 2026-06-17 · 在第 18 页
WMRNN: Weighted Modal Regression Neural Networks for Right Censored Data
· SiM · 2026-06-16 · 在第 18 页
Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance
· SiM · 2026-06-15 · 在第 18 页
Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation
· SiM · 2026-06-14 · 在第 18 页
Doubly robust and efficient calibration of prediction sets for right-censored time-to-event outcomes
· Biometrika · 2026-06-11 · 在第 18 页
Simulation‐Based Power Analysis for Time‐Dependent Area Under Receiver Operating Characteristic Curve Using Approximate Bayesian Computation
· SiM · 2026-06-10 · 在第 18 页
Transfer learning estimation of the accelerated failure time model based on high-dimensional data
· Biometrics · 2026-06-08 · 在第 19 页
Empirical Comparison of Win Ratio and Joint Frailty Models for Recurrent Event Endpoints With Applications in Oncology and Cardiology
· SiM · 2026-06-07 · 在第 19 页
A Nested Copula Model for Recurrent Gap Times With a Dependent Terminal Event
· SiM · 2026-06-07 · 在第 19 页
Pseudo-death: a new measure to evaluate composite outcomes in survival analysis
· JRSSC · 2026-06-05 · 在第 19 页
Rank‐Based Transfer Learning for High‐Dimensional Survival Data With Application to Sepsis Data
· SiM · 2026-06-02 · 在第 20 页
Sample Size Determination for Response‐Adaptive Randomization With Recurrent Event Responses and Unequal Follow‐Up Time
· SiM · 2026-05-31 · 在第 20 页
Nonparametric Tests for Treatment Effect Leveraging Information on Recurrent and Terminal Events and Physiological Decline
· SiM · 2026-05-28 · 在第 21 页
TITE-safety: a robust time-to-event safety monitoring approach for clinical trials
· Biometrics · 2026-05-27 · 在第 21 页
Learning association from multiple intermediate events for dynamic prediction of survival: an application to cardiovascular disease prognosis
· Biometrics · 2026-05-27 · 在第 21 页
Interpretable Deep Regression Models With Interval‐Censored Failure Time Data
· SiM · 2026-05-25 · 在第 21 页
A quantile cure model with partially functional covariate effects
· SMMR · 2026-05-23 · 在第 21 页
Randomized Interventional Effects in Semicompeting Risks, With Application to a Hematopoietic Cell Transplantation Study
· SiM · 2026-05-21 · 在第 21 页
Nonparametric estimation of the total treatment effect with multiple outcomes in the presence of terminal events
· Biometrics · 2026-05-21 · 在第 21 页
Joint modeling of multiple longitudinal biomarkers and survival outcomes via threshold regression: variability as a predictor
· Biometrics · 2026-05-21 · 在第 21 页
Heterogeneity learning in distributed networks with large-scale survival data
· Biometrics · 2026-05-21 · 在第 22 页
Correcting random effect distributions to account for survivorship bias in individual heterogeneity Cormack–Jolly–Seber models
· Biometrics · 2026-05-21 · 在第 22 页
A regularized multi-state model for covariate selection with interval-censored survival data
· Biometrics · 2026-05-21 · 在第 22 页
Likelihood-based modeling of covariate-specific time-dependent receiver operating characteristic curves
· SMMR · 2026-05-20 · 在第 22 页
Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
· SiM · 2026-05-17 · 在第 22 页
A Bayesian Location‐Scale Joint Model for Time‐To‐Event and Multivariate Longitudinal Data With Association Based on Within‐Individual Variability
· SiM · 2026-05-17 · 在第 23 页
Quantile inference for multivariate response regression in joint modeling of longitudinal and survival data
· SMMR · 2026-05-16 · 在第 23 页
A Bayesian phase I/II platform design with survival efficacy endpoint for dose optimization
· SMMR · 2026-05-14 · 在第 23 页
Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs
· Biometrics · 2026-05-12 · 在第 23 页
Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach
· SiM · 2026-05-08 · 在第 23 页
Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
· SiM · 2026-05-05 · 在第 23 页
Proportional Hazards Regression for Interval‐Censored Outcomes With an Interval‐Censored Covariate
· SiM · 2026-05-04 · 在第 24 页
Bayesian Inference for Cluster‐Randomized Trials With Multivariate Outcomes Subject to Both Truncation by Death and Missingness
· SiM · 2026-05-04 · 在第 24 页
Nonparanormal adjusted marginal inference
· Biometrics · 2026-04-29 · 在第 24 页
A double-semiparametric approach for extending mixture cure models with interval-censored data
· SMMR · 2026-04-29 · 在第 24 页
Smooth transformation models for survival analysis: A tutorial using R
· SMMR · 2026-04-27 · 在第 24 页
Mediation Analysis of Failure Time Data Under Interval Censoring
· SiM · 2026-04-27 · 在第 25 页
Win Ratio as an Effect Size Measure Under Non‐Proportional Hazards: A Comparison With Difference in Restricted Mean Survival
· SiM · 2026-04-24 · 在第 25 页
Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time
· SiM · 2026-04-24 · 在第 25 页
Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival
· SiM · 2026-04-22 · 在第 25 页
Novel Influence Diagnostics in Multistate Models for Breast Cancer
· SiM · 2026-04-20 · 在第 25 页
Meta‐Analysis of Median Survival Times With Inverse‐Variance Weighting
· SiM · 2026-04-17 · 在第 25 页
A zero-inflated hierarchical generalized transformation model to address non-normality in spatially-informed cell-type deconvolution
· Biometrics · 2026-04-17 · 在第 25 页
Functional principal component analysis forsparse censored data
· Biometrika · 2026-04-16 · 在第 25 页
Sensitivity Analysis for Unmeasured Confounding in Causal Mediation Analysis With Survival Outcome
· SiM · 2026-04-07 · 在第 26 页
Flexible Modeling of Time‐Dependent Covariate Effects in Survival Models With Correlated Competing Risks: Application to the Evaluation of Risk‐Reducing Salpingo‐Oophorectomy in Women With BRCA1 Pathogenic Variants
· SiM · 2026-04-07 · 在第 26 页
A New Parametric Accelerated Failure Time Model for Semi‐Competing Risks Data
· SiM · 2026-04-06 · 在第 26 页
Vaccine efficacy estimands and power considerations
· SMMR · 2026-04-02 · 在第 26 页
Sensitivity bounds for bias in hazard ratios: A causal hazard perspective
· SMMR · 2026-04-02 · 在第 26 页
Regression for Left‐Truncated and Right‐Censored Data: A Semiparametric Sieve Likelihood Approach
· SiM · 2026-04-02 · 在第 26 页
Randomization‐Based Covariance Analysis for Confidence Intervals of Treatment Comparisons Based on Restricted Mean Survival Time With Categorized Time‐to‐Event Data
· SiM · 2026-04-02 · 在第 26 页
Nonparametric inference for censored data using deep neural networks
· JRSSB · 2026-04-02 · 在第 27 页
Flexible yet Sparse Bayesian Survival Models With Time‐Varying Coefficients and Unobserved Heterogeneity
· SiM · 2026-04-02 · 在第 27 页
Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events
· SiM · 2026-04-02 · 在第 27 页
Semiparametric Joint Modeling for Survival Analysis With Longitudinal Covariates
· JASA · 2026-04-01 · 在第 27 页
Penalized estimation of linear transformation models for interval-censored data with time-dependent covariates
· SMMR · 2026-03-31 · 在第 27 页
Simultaneous clustering and estimation of additive shape invariant models for recurrent event data
· Biometrics · 2026-03-30 · 在第 28 页
Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms
· SiM · 2026-03-30 · 在第 28 页
Palm distributions of superposed point processes for statistical inference
· Biometrika · 2026-03-28 · 在第 28 页
Covariate hypothesis tests for the cure rate in mixture cure models based on martingale difference correlation
· SMMR · 2026-03-27 · 在第 28 页
A Bayesian transformation model for informative partly interval-censored data with covariates subject to measurement error
· SMMR · 2026-03-25 · 在第 28 页
Hypothesis Tests of Direct and Indirect Effects Under Various Semicompeting Risks Models
· SiM · 2026-03-24 · 在第 28 页
Asymptotic validity of Schoenfeld’s sample size formula for the Cox proportional hazards model via the Wald test approach
· SMMR · 2026-03-23 · 在第 28 页
Joint Modeling of Quality of Life and Survival Using a Bayesian Approach in a Retrospective Time Scale
· SiM · 2026-03-19 · 在第 29 页
A robust covariate-balancing method for estimating individualized treatment with censored data
· Biometrics · 2026-03-19 · 在第 29 页
Sample Size Recalculation in Adaptive Group Sequential Study Designs for Comparing Restricted Mean Survival Times
· SiM · 2026-03-18 · 在第 29 页
Variable selection in functional linear Cox model
· Biometrics · 2026-03-16 · 在第 29 页
Variable Significance Testing for the Deep Cox Model
· JASA · 2026-03-16 · 在第 29 页
SurvSTAAR: A Powerful Statistical Framework for Rare Variant Analysis of Time-to-Event Traits in Large-Scale Whole-Genome Sequencing Studies
· JASA · 2026-03-16 · 在第 29 页
Permutation Tests Based on the Copula‐Graphic Estimator and Their Use for Survival Tree Construction
· SiM · 2026-03-16 · 在第 29 页
On Window Mean Survival Time With Interval‐Censored Data
· SiM · 2026-03-16 · 在第 29 页
Accommodating the Analysis Model in Multiple Imputation for the Weibull Mixture Cure Model: Performance Under Penalized Likelihood
· SiM · 2026-03-16 · 在第 30 页
Time‐Varying Hormonal Treatment and Metastasis‐Free Survival Among ER+ Breast Cancer Patients: A Natural History Modelling Approach
· SiM · 2026-03-11 · 在第 30 页
Missingness in Eligibility Criteria for Target Trial Emulation in EHR With Survival Outcomes
· SiM · 2026-03-11 · 在第 30 页
Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time
· SiM · 2026-03-09 · 在第 30 页
Regression analysis of interval-censored competing risks data with missing causes of failure: A direct likelihood approach
· SMMR · 2026-03-04 · 在第 30 页
Using Quadratic Programming to Reconstruct Data From Published Survival and Competing Risks Analyses
· SiM · 2026-03-03 · 在第 30 页
Improved survival analysis with shrinkage Kibria–Lukman estimators in the Cox model: Application to lung cancer data
· SMMR · 2026-03-03 · 在第 30 页
Likelihood Confidence Intervals for Misspecified Cox Models
· SiM · 2026-03-01 · 在第 31 页
The Impact of Two Data‐Generating Processes for Competing Risk Data on the Discrimination and Calibration of Two Types of Competing Risk Regression Models
· SiM · 2026-02-27 · 在第 31 页
Partially Linear Additive Quantile Regression: Theory and Applications to Breast Cancer Patients' Survival
· SiM · 2026-02-27 · 在第 31 页
Inverse Probability Weighting for Recurrent Event Models
· SiM · 2026-02-27 · 在第 31 页
A Model Based on Mixture of Weibull Distributions for Depending Competing Risks Data in the Presence of Long-Term Survivors, and Its Application to Malignant Melanoma Cancer Data
· SiM · 2026-02-27 · 在第 31 页
Estimating conditional survival benefit for the allocation of scarce resources
· SMMR · 2026-02-17 · 在第 32 页
Designing clinical trials for the comparison of single and multiple quantiles with right-censored data
· SMMR · 2026-02-16 · 在第 32 页
A Functional Joint Model for Survival and Multivariate Sparse Functional Data in Multi‐Cohort Alzheimer's Disease Study
· SiM · 2026-02-13 · 在第 32 页
Neural Network Assisted Estimation for the Structural Nested Accelerated Failure Time Models
· SiM · 2026-02-12 · 在第 32 页
Estimands and Doubly Robust Estimation for Cluster-Randomized Trials With Survival Outcomes
· SiM · 2026-02-09 · 在第 33 页
Monitoring time to event in registry data using CUSUMs based on relative survival models
· SMMR · 2026-02-05 · 在第 33 页
Deep Neural Network With a Smooth Monotonic Output Layer for Dynamic Risk Prediction
· SiM · 2026-02-04 · 在第 33 页
Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary Outcomes
· SiM · 2026-02-04 · 在第 33 页
A Powerful and Self-Adaptive Weighted Logrank Test
· SiM · 2026-02-04 · 在第 33 页
Long-term memory effects of an incremental blood pressure intervention in a mortal cohort
· Biometrics · 2026-02-03 · 在第 33 页
Bayesian inference for Cox regression models using catalytic prior distributions
· Biometrics · 2026-02-03 · 在第 34 页
Strategy to Control Biases in Prior Event Rate Ratio Method, With Application to Palliative Care in Patients With Advanced Cancer
· SiM · 2026-01-30 · 在第 34 页
A non-proportional hazards cure model with an application to gastric cancer data analysis
· SMMR · 2026-01-30 · 在第 34 页
Statistical methods for clustered competing risk data when the event types are only available in a training dataset
· SMMR · 2026-01-29 · 在第 34 页
Discrimination performance in illness-death models with interval-censored disease data
· SMMR · 2026-01-29 · 在第 34 页
Structured Nonlinear Cure Model With Deep Neural Networks for High‐Dimensional Survival Analysis
· SiM · 2026-01-22 · 在第 35 页
Finite Mixtures of Multivariate t Linear Mixed‐Effects Models for Censored Longitudinal Data With Concomitant Covariates
· SiM · 2026-01-22 · 在第 35 页
Bayesian Variable Selection With l1‐Ball for Spatially Partly Interval‐Censored Data
· SiM · 2026-01-22 · 在第 35 页
Adaptive Incorporation of External Summary Information in the Cox Regression Under Population Heterogeneity
· SiM · 2026-01-22 · 在第 35 页
A DNN-Based Weighted Partial Likelihood for Partially Linear Subdistribution Hazard Model
· SiM · 2026-01-22 · 在第 35 页
A Bayesian Multilevel Joint Modeling of Longitudinal and Survival Outcomes in Cluster Randomized Controlled Trial Studies
· SiM · 2026-01-22 · 在第 35 页
Hazard-based distributional regression via ordinary differential equations
· SMMR · 2026-01-19 · 在第 35 页
Generalized pairwise comparisons using pseudo-observations for time-to-event censored data in a randomized controlled trial setting
· SMMR · 2026-01-19 · 在第 35 页
Dynamic prediction of interval-censored failure time data with longitudinal marker
· SMMR · 2026-01-19 · 在第 35 页
A Path-Specific Effect Approach to Mediation Analysis With Time-Varying Mediators and Time-to-Event Outcomes Accounting for Competing Risks
· SiM · 2026-01-19 · 在第 36 页
Restricted mean survival time in cluster randomized trials with a small number of clusters: Improving variance estimation of the intervention effect from the pseudo-values regression
· SMMR · 2026-01-12 · 在第 36 页
Assessing the Benefits and Burdens of Preventive Interventions
· SiM · 2026-01-12 · 在第 36 页
A two-stage joint modeling approach for multiple longitudinal markers and time-to-event data
· SMMR · 2026-01-12 · 在第 36 页
Semiparametric piecewise accelerated failure time model for the analysis of immune-oncology clinical trials
· Biometrics · 2026-01-06 · 在第 36 页
Localizing Strictly Proper Scoring Rules
· JASA · 2026-01-05 · 在第 37 页
SPARCC: Semi-Parametric Robust Estimation in a Right-Censored Covariate Model
· JASA · 2026-01-02 · 在第 37 页
Joint model with latent disease age: Overcoming the need for reference time
· SMMR · 2026-01-02 · 在第 37 页
Functional varying-coefficient Cox model and its application
· SMMR · 2026-01-02 · 在第 37 页
Probabilistic Rainfall Downscaling: Joint Generalized Neural Models with Censored Spatial Gaussian Copula
· JMLR · 2026 · 在第 39 页
Optimal Dynamic Treatment Regimes for High-Dimensional Accelerated Failure Time Model
· SiM · 2026 · 在第 39 页
Network Meta-Analysis of Survival Outcomes With Non-Proportional Hazards Using Flexible M-Splines
· SiM · 2026 · 在第 40 页
Information Design in Common Value Auction With Moral Hazard: Application to OCS Leasing Auctions
· Econometrica · 2026 · 在第 40 页
Exploring Novel Uncertainty Quantification through Forward Intensity Function Modeling
· JMLR · 2026 · 在第 41 页
Efficient estimation for deep generalized accelerated hazards models with interval-censored data
· Biometrics · 2026 · 在第 42 页
Deep Neural Network for Estimating General Risk Scores with Right Censored Data
· JMLR · 2026 · 在第 42 页
Bounds for the regression parameters in dependently censored survival models
· JRSSB · 2026 · 在第 43 页